Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best cancer stocks to invest in now. On February 26, Revolution Medicines, Inc. (NASDAQ:RVMD) CEO Mark A. Goldsmith reiterated that the company has made significant progress in developing a broad portfolio of RAS(ON) inhibitors across multiple disease settings. Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs Daraxonrasib, a pioneering RAS(ON) multi-selective inhibitor, has already shown an unprecedented clin ...